Skip to content

The Peer Genetic Study

Peer-Based Intervention for Genetic Evaluation for Prostate Cancer Among African American Men: The Peer Genetic Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05011799
Enrollment
149
Registered
2021-08-18
Start date
2020-01-08
Completion date
2024-09-28
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subject, Prostate Carcinoma

Brief summary

This trial studies how well a peer-based health education program works in reducing barriers and changing attitudes and beliefs of prostate cancer genetic screening in African American participants with or without a previous personal or family history of prostate cancer. Participating in a peer-based health educational program may help participants learn more about prostate cancer and how their personal or family history of disease may increase their risk of prostate cancer.

Interventions

Receive prostate cancer educational materials

OTHERQuestionnaire Administration

Ancillary studies

OTHEREducational Intervention

Attend peer-led education sessions

Sponsors

Thomas Jefferson University
Lead SponsorOTHER
United States Department of Defense
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
35 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Able to read and speak English comfortably * With or without a personal or family history of PCA * Do not need to be an established patient at CityLife Neighborhood Clinic in order to participate

Exclusion criteria

* Do not read or speak English comfortably * Men who participated in a focus group will be excluded from participating in the intervention

Design outcomes

Primary

MeasureTime frameDescription
Change in of decisional conflictBaseline up to 2 monthsWill be assessed by the 4-item Sure of myself; Understand information; Risk-benefit ratio; Encouragement (SURE) scale. To compute a summary decisional conflict score, the Likert-scaled responses will be averaged across the SURE item responses provided by a subject completing at least 2 of the 4 questions. The change in decisional conflict scores between baseline and endpoint at 2-months will be calculated and group means for these changes compared between subjects randomized to receive control materials vs. those randomized to receive the peer health education intervention (i.e., by intention to treat). The significance of the difference will be evaluated at the 0.05 level using a two-sided Student's t-test. The assumptions for this test will be carefully evaluated. If the changes are substantially skewed, they will be summarized with group medians and evaluated for significant differences by the nonparametric Wilcoxon's rank sum test.
Awareness of risks and benefits of genetic testingUp to 2 months post studyWill be summarized in tables with descriptive statistics or graphically in data plots at each time they are assessed along with changes in responses over time. Will investigate imbalances in these data for potential confounding of primary and exploratory endpoint analyses and investigate disparities and intervention effect modification in various subgroups of subjects.
Perceptions of genetic testingUp to 2 months post studyWill be summarized in tables with descriptive statistics or graphically in data plots at each time they are assessed along with changes in responses over time.
Genetic testingUp to 2 months post studyWill be summarized in tables with descriptive statistics or graphically in data plots at each time they are assessed along with changes in responses over time.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026